Cargando…
Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study
INTRODUCTION: The UK shielding policy intended to protect people at the highest risk of harm from COVID-19 infection. We aimed to describe intervention effects in Wales at 1 year. METHODS: Retrospective comparison of linked demographic and clinical data for cohorts comprising people identified for s...
Autores principales: | Snooks, H., Watkins, A., Lyons, J., Akbari, A., Bailey, R., Bethell, L., Carson-Stevens, A., Edwards, A., Emery, H., Evans, B.A., Jolles, S., John, A., Kingston, M., Porter, A., Sewell, B., Williams, V., Lyons, R.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928733/ https://www.ncbi.nlm.nih.gov/pubmed/36933354 http://dx.doi.org/10.1016/j.puhe.2023.02.008 |
Ejemplares similares
-
P3 How Much Did the COVID-19 Shielding Policy Cost in Wales? Results of a Cost Analysis Within the EVITE Immunity Evaluation
por: Sewell, B., et al.
Publicado: (2022) -
Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study
por: Evans, Bridie Angela, et al.
Publicado: (2022) -
The cost of implementing the COVID-19 shielding policy in Wales
por: Sewell, Bernadette, et al.
Publicado: (2023) -
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
por: Porter, Alison, et al.
Publicado: (2023) -
COVID-19 vaccination uptake in people with epilepsy in wales
por: Strafford, H., et al.
Publicado: (2023)